BIOCARTIS GROUP NV

BCART
Real-time Quote. Real-time  - 06/22 04:00:14 am
3.945EUR +1.68%

Turn to zoom
Prev.3.8800
Open3.9000
High3.9500
Low3.9000
Volume11 717
Latest news
06/04
06/04
05/17
05/14
Chart BIOCARTIS GROUP NV
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBearishNeutral
Resistance4,154,264,98
Spread/Res.-4,9%-7,3%-21%
Spread/Supp.3,4%3,4%5,8%
Support3,823,823,73
Financials
Sales 2021 58,2 M 69,2 M 69,2 M
Net income 2021 -61,0 M -72,6 M -72,6 M
Net Debt 2021 88,0 M 105 M 105 M
P/E ratio 2021 -
Yield 2021 -
Capitalization 223 M 266 M 266 M
EV / Sales 2021 5,35x
EV / Sales 2022 4,36x
Nbr of Employees 484
Free-Float 83,6%
Company
Biocartis Group NV is a Belgium-based company, which specializes in the development of molecular diagnostic systems, especially for the treatment of cancers and infectious diseases, the products ensure the analysis of biomolecules associated with risk factors, early detection, treatment selection...

>> Read more
Sector :
Medical Equipment
Calendar :
2021-09-02 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 3
Average target price 7,33 €
Last Close Price 3,88 €
Spread / Highest target 106%
Spread / Average Target 89,0%
Spread / Lowest Target 67,5%